PDS Biotechnology (NASDAQ:PDSB) Cut to “Sell” at Wall Street Zen
PDS Biotechnology (NASDAQ:PDSB – Get Free Report) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Saturday. Separately, HC Wainwright reissued a “buy” rating and issued a $13.00 target price on shares of PDS Biotechnology in a research note on Wednesday. Get Our Latest […]
PDS Biotechnology (NASDAQ:PDSB – Get Free Report) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Saturday. Separately, HC Wainwright reissued a “buy” rating and issued a $13.00 target price on shares of PDS Biotechnology in a research note on Wednesday. Get Our Latest […]
